MrTommaso Barba
Research Postgraduate
Department of Brain Sciences - Faculty of Medicine
- Research PostgraduateDepartment of Brain Sciences - Faculty of Medicine
- Sir Alexander Fleming Building, South Kensington Campus, United Kingdom
BIO
Tommaso Barba is a PhD candidate at the Centre for Psychedelic Research, Imperial College London, supervised by Dr. David Erritzoe, Prof. David Nutt, Dr. Chris Timmermann, and Dr. Kate Godfrey. With a background in neuroscience and psychoanalysis, he graduated cum laude from Maastricht University with a Master of Research in Cognitive and Clinical Neuroscience. Since September 2020, Tommaso has been with the Centre for Psychedelic Research, initially as a research assistant and now as a PhD scholar, focusing on neuropsychopharmacological and basic science projects.
Tommaso's research centers on the brain effects of short-acting psychedelics such as DMT and 5-MeO-DMT, currently conducting the first neuroimaging trials of these compound in laboratory settings with Dr Timmermann. He also explores the potential role of psychedelics in treating depression and enhancing well-being. Tommaso has published over ten scientific papers, including five as the first author, in journals such as The Lancet EClinical Medicine and Nature Scientific Reports. Tommaso’s work has been widely recognised and covered by prominent media outlets, including Forbes USA, The Times, The Telegraph, Rolling Stone, and CNN.
Tommaso has received prestigious awards, including the Public Engagement Prize from Imperial College London, the Poster Award from the European College of Neuropsychopharmacology (ECNP), and the British Journal of Psychiatry Award for his study "Effects of psilocybin versus escitalopram on rumination and thought suppression in depression."
His interests also include the impact of psychedelics and MDMA on couples' intimacy, advocating for their potential in improving couples' connection within therapeutic settings. Additionally, Tommaso collaborates with universities and startups in Italy and the USA.
Tommaso's research centers on the brain effects of short-acting psychedelics such as DMT and 5-MeO-DMT, currently conducting the first neuroimaging trials of these compound in laboratory settings with Dr Timmermann. He also explores the potential role of psychedelics in treating depression and enhancing well-being. Tommaso has published over ten scientific papers, including five as the first author, in journals such as The Lancet EClinical Medicine and Nature Scientific Reports. Tommaso’s work has been widely recognised and covered by prominent media outlets, including Forbes USA, The Times, The Telegraph, Rolling Stone, and CNN.
Tommaso has received prestigious awards, including the Public Engagement Prize from Imperial College London, the Poster Award from the European College of Neuropsychopharmacology (ECNP), and the British Journal of Psychiatry Award for his study "Effects of psilocybin versus escitalopram on rumination and thought suppression in depression."
His interests also include the impact of psychedelics and MDMA on couples' intimacy, advocating for their potential in improving couples' connection within therapeutic settings. Additionally, Tommaso collaborates with universities and startups in Italy and the USA.
FACULTY
- Faculty of Medicine
POSITION NAME
- Research Postgraduate